T1	Pharmacological_substance 9 17	Rifampin
N1000 	Reference T1 MeSH:D012293	Rifampin
N1001 	Reference T1 MeSH:D012293	Rifampin
T2	Disorder 29 45	thrombocytopenia
N1 	Reference T2 UMLS:C0040034	thrombocytopenia
T3	Pharmacological_substance 77 85	Rifampin
N1002 	Reference T3 MeSH:D012293	Rifampin
T4	Disorder 140 149	hepatitis
N2 	Reference T4 UMLS:C0019158	hepatitis
T5	Disorder 151 170	acute renal failure
N3 	Reference T5 UMLS:C0022660	acute renal failure
N4 	Reference T5 UMLS:C3854173	acute renal failure
T6	Disorder 172 188	hemolytic anemia
N5 	Reference T6 UMLS:C0002878	hemolytic anemia
T7	Disorder 194 210	thrombocytopenia
N6 	Reference T7 UMLS:C0040034	thrombocytopenia
T8	Disorder 212 228	Thrombocytopenia
N7 	Reference T8 UMLS:C0040034	Thrombocytopenia
T9	Pharmacological_substance 329 337	rifampin
N1003 	Reference T9 MeSH:D012293	rifampin
T10	Disorder 349 365	thrombocytopenia
N8 	Reference T10 UMLS:C0040034	thrombocytopenia
T11	Disorder 429 451	pulmonary tuberculosis
N9 	Reference T11 UMLS:C0041327	pulmonary tuberculosis
T14	Pharmacological_substance 561 569	rifampin
N1004 	Reference T14 MeSH:D012293	rifampin
T17	Pharmacological_substance 709 717	rifampin
N1005 	Reference T17 MeSH:D012293	rifampin
T18	Disorder 768 794	Mycobacterium tuberculosis
N10 	Reference T18 UMLS:C0041296	Mycobacterium tuberculosis
T22	Disorder 996 1013	adverse reactions
N11 	Reference T22 UMLS:C0559546	adverse reactions
T24	Disorder 109 131	severe adverse effects
N12 	Reference T24 UMLS:C0879626	severe adverse effects
T26	Speculation_cue 86 89	can
T16	Subject 372 388	indigent patient
